Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - isolation
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel Human Rotavirus Vaccine CDC-6 Strain for Impacted Subgroup, the Lewis Negative Population
Rotaviral infection is the most common gastrointestinal illness of children in the world, affecting both developed and developing economies. There is no specific drug treatment for rotavirus infection. Vaccination and good hygiene are key to prevention. Approximately 5-10% of the world's population are Lewis histoblood group antigen negative, that percentage...
Published: 10/28/2024
|
Inventor(s):
Yuhuan Wang
,
Baoming Jiang
Keywords(s):
Candidate
,
CHARACTERIZATION
,
G9P[6]
,
Human
,
Isolation
,
NCIRD
,
NCIRD-DVD
,
rotavirus
,
Strain
,
Vaccine
,
VLXXXX
,
WBXXXX
,
WFXXXX
,
WGXXXX
,
WHXXXX
,
WIXXXX
,
WNXXXX
,
XKXXXX
,
YAXXXX
,
YBXXXX
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines
,
Application > Consumer Products
,
Application > Diagnostics
,
Application > Research Materials
,
Application > Occupational Safety and Health
Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein
Inhibiting the ability of HIV-1, the virus that causes AIDS, to infect cells is one approach to both prevention and treatment of HIV. Scientists at the NIAID Vaccine Research Center have isolated and characterized neutralizing antibodies (VRC01, 02, 03, and 07) that bind to the CD4 binding site of HIV-1 envelope glycoprotein gp120. These human monoclonal...
Published: 10/28/2024
|
Inventor(s):
Richard Wyatt
,
Xueling Wu
,
Yuxing Li
,
Carl-Magnus Hogerkorp
,
Mario Roederer
,
Zhi-yong Yang
,
Gary Nabel
,
Peter Kwong
,
Tongqing Zhou
,
Mark Connors
,
Gilad Ofek
,
Yongping Yang
,
Jiang Zhu
,
Lawrence Shapiro
,
William Schief
,
Rebecca Rudicell
,
Ivelin Georgiev
,
Young Do Kwon
,
Baoshan Zhang
,
Gwo-yu Chauang
,
Wei Shi
,
Gwo-Yu Chuang
,
John Mascola
Keywords(s):
Against
,
antibodies
,
Antibodies.
,
ANTIBODY
,
Antibody-based
,
B-Cells
,
Broadly
,
Chain
,
Constructs
,
CREATION
,
DA4AXX
,
DB4AXX
,
DC5AXX
,
DD2XXX
,
Epitope-Specific
,
Expressing
,
FUNCTION
,
Further
,
GENERAL
,
GLYCOPROTEIN
,
gp120
,
HIV
,
HIV-1
,
Identity
,
Immunoadesion
,
Immunoadhesin
,
Isolation
,
Listed LPM Thalhammer-Reyero as of 4/15/2015
,
MODE
,
Modifications
,
monoclonal
,
Monoco
,
Neutizing
,
Neutralization
,
Neutralizing
,
Novel
,
Patent Category - Biotechnology
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
Probes
,
Single
,
Specific
,
VRC03
,
VRC03
Isolation
Category(s):
Collaboration Sought > Licensing
,
Application > Therapeutics
,
Application > Vaccines
,
TherapeuticArea > Infectious Disease
,
Application > Diagnostics
,
Application > Research Materials
Diagnostics, Vaccines, and Delivery-Vehicles Related to Novel Phlebovirus
This CDC invention relates to primers and probes that specifically hybridize with Heartland virus (HRTLDV), a unique member of the genus Phlebovirus. It further relates to polyclonal antibodies specific for HRTLDV proteins. Serological detection assays using HRTLDV nucleic acid molecules, proteins, probes, primers, and antibodies are provided. Importantly,...
Published: 10/28/2024
|
Inventor(s):
Stuart Nichol
,
William Nicholson
,
Cynthia Goldsmith
,
Aubree Kelly
,
Laura McMullan
Keywords(s):
AC4XXX
,
ACXXXX
,
ANTIBODY
,
ANTIGEN
,
AXXXXX
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
Compositions
,
DA4BXX
,
DA4XXX
,
DAXXXX
,
DC1XXX
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DDXXXX
,
Delivery
,
delivery system
,
DEVELOPED
,
diagnostic
,
DXXXXX
,
GB2CXX
,
GB2XXX
,
GBXXXX
,
GCXXXX
,
GENE THERAPY
,
gene transfer
,
GXXXXX
,
heartland
,
heartland virus
,
Hospitalized
,
Identification
,
ISOLATES
,
Isolation
,
Methods
,
Missouri
,
Novel
,
PATHOGENIC
,
PHLEBOVIRUS
,
PLATFORM
,
Platforms
,
sequence
,
therapeutic
,
therapeutic candidates
,
THEREOF
,
TICK
,
TICK-BORNE
,
TICKS
,
TWO
,
Vaccine
,
VACCINE VECTORS
,
Vector
,
Vector-based
,
Vector-borne
,
Vector-borne diseases
,
VETERINARY
,
VETERINARY vaccine
,
viral
,
virus
,
VLXXXX
,
VOXXXX
,
WBXXXX
,
WDXXXX
,
WFXXXX
,
WIXXXX
,
WJXXXX
,
XAXXXX
,
XCXXXX
,
XHXXXX
,
YAXXXX
,
YBXXXX
,
Zoo
Category(s):
Collaboration Sought > Licensing
,
ResearchProducts > Antibodies
,
ResearchProducts > Research Equipment
,
Application > Research Materials
,
TherapeuticArea > Immunology
,
Application > Diagnostics
,
Application > Vaccines
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
Application > Occupational Safety and Health
,
Application > Consumer Products
Isolation
, Cloning and Characterization of New Adeno-Associated Virus (AAV) Serotypes
Adeno-associated viruses (AAV) are used in gene delivery, but with limited success due to toxicity. The novel AAVs described in this technology may be more effective and useful in gene therapy applications. This invention relates to new adeno-associated viruses (AAV), vectors and particles derived therefrom and also provides methods for delivering...
Published: 10/28/2024
|
Inventor(s):
John (Jay) Chiorini
,
Michael Schmidt
Keywords(s):
Adeno-associated
,
CHARACTERIZATION
,
Cloning
,
GB2A2X
,
GB2AXX
,
GB2XXX
,
GBXXXX
,
GXXXXX
,
Isolation
,
Novel
,
Serotypes
,
virus
Category(s):
Application > Therapeutics